ArticleBone marrow transplantation2003

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT).

R Syme et al.PubMed ↗Publisher ↗

No numbers read from the abstract.